Murphy, G P <br/><br/>
Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients.  [electronic resource] 

 -  The Prostate  Apr 2000 
 - 59-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-4137 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0045(20000401)43:1<59::aid-pros8>3.0.co;2-d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Surface<br/>Carboxypeptidases--therapeutic use<br/>Dendritic Cells--transplantation<br/>Drug Resistance<br/>Glutamate Carboxypeptidase II<br/>Hormones--therapeutic use<br/>Humans<br/>Male<br/>Peptide Fragments--therapeutic use<br/>Prostatic Neoplasms--secondary<br/>Retreatment<br/>Treatment Outcome